hydrazine has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apperley, J; Caligiuri, MA; Eisfeld, AK; Ellis, JJ; Ferenchak, G; Gabrail, NY; Garzon, R; Goldman, JM; Harb, JG; Hokland, P; Kauffman, MG; Landesman, Y; Marcucci, G; Milojkovic, D; Neviani, P; Oaks, JJ; Perrotti, D; Reid, A; Roy, DC; Santhanam, R; Shacham, S; Smith, CL; Walker, CJ | 1 |
| Abraham, SA; Holyoake, TL | 1 |
2 other study(ies) available for hydrazine and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.
Topics: Adult; Animals; Antigens, CD34; Antineoplastic Agents; Apoptosis; Cell Proliferation; Clinical Trials, Phase I as Topic; DNA-Binding Proteins; Drug Evaluation, Preclinical; Exportin 1 Protein; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Histone Chaperones; Humans; Hydrazines; Karyopherins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Protein Transport; Receptors, Cytoplasmic and Nuclear; Ribonucleoproteins; Transcription Factors; Triazoles | 2013 |
Redirecting traffic using the XPO1 police.
Topics: Animals; Antineoplastic Agents; Exportin 1 Protein; Gene Expression Regulation, Leukemic; Humans; Hydrazines; Karyopherins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cytoplasmic and Nuclear; Triazoles | 2013 |